RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BL PharmTech Stock

BL PharmTech Net Income 2025

BL PharmTech Net Income

-5.71 B KRW

Ticker

065170.KQ

ISIN

KR7065170003

In 2025, BL PharmTech's profit amounted to -5.71 B KRW, a 3,733.74% increase from the -148.85 M KRW profit recorded in the previous year.

The BL PharmTech Net Income history

YEARNET INCOME (undefined KRW)
2024-5.71
2023-0.15
2022-13.9
2021-20.21
2020-17.95
2019-11.82
20181.3
2017-3.06
2016-5.08
2015-6.51
2014-1.04
2013-3.08
2012-2.65
20110.17
20100.27
2009-7.88
2008-16.55
2007-0.29
20060.41
20051.52

BL PharmTech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into BL PharmTech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BL PharmTech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BL PharmTech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of BL PharmTech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into BL PharmTech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing BL PharmTech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BL PharmTech’s growth potential.

BL PharmTech Revenue, EBIT and net profit per share

DateBL PharmTech RevenueBL PharmTech EBITBL PharmTech Net Income
20248.81 B undefined-3.22 B undefined-5.71 B undefined
202324.53 B undefined-6.79 B undefined-148.85 M undefined
202222.52 B undefined-4.45 B undefined-13.9 B undefined
202184.44 B undefined-3.43 B undefined-20.21 B undefined
202065.69 B undefined-2.03 B undefined-17.95 B undefined
201958.87 B undefined-2.79 B undefined-11.82 B undefined
201887.69 B undefined2.09 B undefined1.3 B undefined
201783.71 B undefined2.77 B undefined-3.06 B undefined
201673.96 B undefined1.82 B undefined-5.08 B undefined
201557.15 B undefined-153 M undefined-6.51 B undefined
201461.6 B undefined1.97 B undefined-1.04 B undefined
201350.7 B undefined1.9 B undefined-3.08 B undefined
201261.34 B undefined2.29 B undefined-2.65 B undefined
201154.14 B undefined4.38 B undefined166 M undefined
201057.25 B undefined2.28 B undefined268 M undefined
200949.87 B undefined-2.15 B undefined-7.88 B undefined
200844.04 B undefined-919 M undefined-16.55 B undefined
200730.32 B undefined169 M undefined-293 M undefined
200619.54 B undefined-975 M undefined414 M undefined
200517.39 B undefined1.54 B undefined1.52 B undefined

BL PharmTech stock margins

The BL PharmTech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BL PharmTech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BL PharmTech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the BL PharmTech's sales revenue. A higher gross margin percentage indicates that the BL PharmTech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the BL PharmTech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the BL PharmTech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BL PharmTech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BL PharmTech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BL PharmTech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

BL PharmTech Margin History

BL PharmTech Gross marginBL PharmTech Profit marginBL PharmTech EBIT marginBL PharmTech Profit margin
202467.24 %-36.52 %-64.81 %
202355.29 %-27.7 %-0.61 %
202256.48 %-19.75 %-61.73 %
202124.96 %-4.06 %-23.94 %
202030.99 %-3.1 %-27.32 %
201938.09 %-4.73 %-20.08 %
201839.44 %2.38 %1.48 %
201733.25 %3.31 %-3.65 %
201634.39 %2.45 %-6.86 %
201534.78 %-0.27 %-11.4 %
201443.48 %3.2 %-1.69 %
201339.03 %3.74 %-6.07 %
201240.56 %3.73 %-4.32 %
201144.3 %8.1 %0.31 %
201032.71 %3.99 %0.47 %
200915.67 %-4.32 %-15.8 %
200813.78 %-2.09 %-37.57 %
200713.21 %0.56 %-0.97 %
200617.85 %-4.99 %2.12 %
200528.91 %8.88 %8.73 %

BL PharmTech Aktienanalyse

What does BL PharmTech do?

BL PharmTech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding BL PharmTech's Profit Margins

The profit margins of BL PharmTech represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of BL PharmTech's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating BL PharmTech's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

BL PharmTech's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When BL PharmTech’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about BL PharmTech stock

How much profit has BL PharmTech made this year?

BL PharmTech has made -5.71 B KRW this year.

How has the profit developed compared to last year?

The profit has increased by 3,733.74% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does BL PharmTech publish its earnings?

BL PharmTech publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of BL PharmTech?

The profits of BL PharmTech are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of BL PharmTech?

You can learn more about the earnings of BL PharmTech by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does BL PharmTech pay?

Over the past 12 months, BL PharmTech paid a dividend of 316.21 KRW . This corresponds to a dividend yield of about 40.33 %. For the coming 12 months, BL PharmTech is expected to pay a dividend of 0 KRW.

What is the dividend yield of BL PharmTech?

The current dividend yield of BL PharmTech is 40.33 %.

When does BL PharmTech pay dividends?

BL PharmTech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BL PharmTech?

BL PharmTech paid dividends every year for the past 0 years.

What is the dividend of BL PharmTech?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is BL PharmTech located?

BL PharmTech is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von BL PharmTech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BL PharmTech from 4/14/2005 amounting to 120 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2004.

When did BL PharmTech pay the last dividend?

The last dividend was paid out on 4/14/2005.

What was the dividend of BL PharmTech in the year 2024?

In the year 2024, BL PharmTech distributed 0 KRW as dividends.

In which currency does BL PharmTech pay out the dividend?

The dividends of BL PharmTech are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BL PharmTech

Our stock analysis for BL PharmTech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BL PharmTech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.